# Ardelyx, Inc. (ARDX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ARDX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 215.35M | $ -54.33M | $ -38.72M | $ 256.19M | $ 149.01M |
| 2025 | $ 417.06M | $ -63.07M | $ -45.03M | $ 211.60M | $ 166.95M |
| 2024 | $ 350.66M | $ -41.14M | $ -48.16M | $ 153.44M | $ 173.29M |
| 2023 | $ 134.57M | $ -71.44M | $ -97.38M | $ 55.98M | $ 166.82M |
| 2022 | $ 58.27M | $ -75.08M | $ -78.84M | $ 36.46M | $ 98.33M |
| 2021 | $ 12.00M | $ -188.00M | $ -183.55M | $ 45.50M | $ 82.62M |
| 2020 | $ 9.64M | $ -120.15M | $ -104.16M | $ 55.44M | $ 126.11M |
| 2019 | $ 6.82M | $ -122.54M | $ -99.14M | $ 57.31M | $ 186.66M |
| 2018 | $ 3.44M | $ -120.58M | $ -93.22M | $ 49.21M | $ 115.81M |
| 2017 | $ 56.58M | $ -86.67M | $ -90.99M | $ 0 | $ 139.31M |
| 2016 | $ 0 | $ -154.62M | $ -134.01M | $ 0 | $ 193.15M |
| 2015 | $ 33.73M | $ -41.59M | $ -105.72M | $ 0 | $ 108.90M |
| 2014 | $ 44.68M | $ -4.54M | $ 16.31M | $ 0 | $ 60.68M |
| 2013 | $ 41.14M | $ -9.34M | $ 2.18M | $ 0 | $ -7.32M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1.72 |
| Liabilities / Eq | 2.86 |
| Current Ratio | 3.34 |

## Other views

- [Metrics](https://sponda.capital/en/ARDX.md)
- [Charts](https://sponda.capital/en/ARDX/charts.md)
- [Compare](https://sponda.capital/en/ARDX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.